Beth E. Williams

ORCID: 0000-0002-4742-966X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Opioid Use Disorder Treatment
  • Mental Health and Patient Involvement
  • Pain Management and Opioid Use
  • HIV, Drug Use, Sexual Risk
  • Public Health Policies and Education
  • Musculoskeletal pain and rehabilitation
  • Substance Abuse Treatment and Outcomes
  • Patient-Provider Communication in Healthcare
  • Hepatitis C virus research
  • Food Security and Health in Diverse Populations
  • Building Energy and Comfort Optimization
  • Influenza Virus Research Studies
  • Vaccine Coverage and Hesitancy
  • Maternal Mental Health During Pregnancy and Postpartum
  • Maternal and fetal healthcare
  • SARS-CoV-2 and COVID-19 Research
  • HIV/AIDS Research and Interventions
  • Energy Efficiency and Management
  • Statistical Methods in Clinical Trials
  • Health Policy Implementation Science
  • Radiology practices and education
  • Pain Management and Placebo Effect
  • COVID-19 and healthcare impacts
  • Disaster Response and Management
  • Cancer Genomics and Diagnostics

Oregon Health & Science University
2024-2025

Consumer VOICE
2025

VA Portland Health Care System
2021-2022

Central City Concern
2019-2021

Vantage View (United States)
2020

Medical Group Management Association
2020

Yale University
2016

Background: Haematopoietic stem cell transplant (HCT) is a curative therapy for various paediatric conditions but associated with significant morbidity and mortality, particularly in children requiring intensive care, facing delayed immune reconstitution or prolonged viral reactivation. Due to the rarity heterogeneity of HCT, traditional randomised controlled trials are challenging. Adaptive platform (APTs), which evaluate multiple interventions across subgroups, offer solution , typically...

10.1101/2025.03.21.25324374 preprint EN cc-by-nc-nd medRxiv (Cold Spring Harbor Laboratory) 2025-03-21
Erin E. Krebs William C. Becker David Nelson Beth DeRonne Agnes Jensen and 95 more Allyson M. Kats Benjamin J. Morasco Joseph W. Frank Una E. Makris Kelli D. Allen Jennifer C. Naylor Amanda S. Mixon Amy M. Bohnert Thomas E. Reznik Jacob T. Painter Teresa J. Hudson Hildi Hagedorn Jennifer K. Manuel Brian Borsari Natalie Purcell Patrick Hammett Erin C. Amundson Robert D. Kerns Monica R. Barbosa Caitlin Garvey Ervin E. Jones Maureen Y. Noh Jennifer B. Okere Sujata Bhushan John Pinsonnault Beth E. Williams Ellen Herbst Pooja Lagisetty Sara Librodo Payal S. Mapara Elizabeth Son Christina Tat Rebecca A. Marraffa Randy L. Seys Catherine Baxley Karen H. Seal Audrey Abelleira Melissa Adams Adam Anicich Brett Ankawi Stephanie Arnold Anuj Aryal David C. Atkins Timothy Atkinson Kristen Backe Matthew J. Bair Surabhi Bajpai Kristeen Baller Ann Bangerter Steven Barnett Stephen T. Bartlett M. Bartnik Jonathan J. Baskin Ronald Blehm Philip P. Bloechl Natassia Boening Nicole Boesch Sondra Bolander Marianne Bolf John Bonchak Karen Booth Margaret Bordanea Dominika Borowa Marnie Bowden Sally Britnell Daniel F. Broderick Carrie Bronars Kristen Brooks Cheryl Brown Erin A. Brudvik Katrina Buchanan Carolyn Buesgens Michele Buonora Ronald M. Burch Caitlin Burton Christopher Butler Susan Byerly Catherine Byrd G. Vernon Byrd Emily M. Hagel Campbell Desmond Cariveau Suzanne Carmody Medenna Carr Thomas Carr Dana Cervone Michael J. Chandler K.W. Clarke Michael Clay William B. Coy Michael Craine David H. Culver Andrea Cutting Alisher R. Dadabayev David Daly Rose Degerstrom

Importance Patients prescribed long-term opioid therapy for chronic pain often experience unrelieved pain, poor quality of life, and serious adverse events. Objective To compare the effects integrated team (IPT) vs pharmacist collaborative management (PCM) on dosage. Design, Setting, Participants This study was a pragmatic multisite 12-month randomized comparative effectiveness trial with masked outcome assessment. were recruited from October 2017 to March 2021; follow-up completed June...

10.1001/jamainternmed.2024.6683 article EN JAMA Internal Medicine 2024-12-09

Abstract Background One in three women will deliver by cesarean, a procedure that can be life saving, but which also carries short‐ and long‐term risks. There is growing interest preventing primary cesarean deliveries, while optimizing the health of mother infant. The aim this study was to use participatory action strategies ethnographic interview data collected from diverse stakeholders birth (caregivers, women, policymakers) about facilitators barriers achievement vaginal first‐time...

10.1111/birt.12245 article EN Birth 2016-08-08

<title>Abstract</title> <bold>Introduction:</bold> Buprenorphine is an effective first-line treatment for opioid use disorder (OUD) that substantially reduces morbidity and mortality. For patients using illicitly-manufactured fentanyl (IMF), however, transitioning to buprenorphine can be challenging. Evidence lacking how best make this transition in the outpatient setting. A shared decision-making (SDM) approach has been found benefit with OUD but not studied initiation. We sought explore...

10.21203/rs.3.rs-4595695/v1 preprint EN Research Square (Research Square) 2024-07-17

Background: Hepatitis C Virus (HCV) treatment in people who inject drugs (PWID) is a key component of elimination models but PWID face substantial barriers to access. Despite data showing outcomes among on medications for opioid use disorder (MOUD) are similar non-PWID outcomes, few studies examine with only syringe services support. Objectives: To evaluate the effect recruitment HCV elbasvir/grazoprevir (E/G) program (SSP) as compared an MOUD disorder. Methods: This real-world, multi-site...

10.5812/hepatmon.114781 article EN Hepatitis Monthly 2021-10-26
Coming Soon ...